Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | METAP1 | P53582 | 2/20 | 0.45 |
| ▸ | CCR1 | P32246 | 2/20 | 0.45 |
| ▸ | CCR5 | P51681 | 2/20 | 0.45 |
| ▸ | CCR8 | P51685 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.45 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30610286 | 1.00 | KDM4E (0.47) | KDM4ENPC1GABRA1GABRA5GABRA3 | |
| SCHEMBL30610287 | 1.00 | KDM4E (0.47) | KDM4ENPC1GABRA1GABRA5GABRA3 | |
| SCHEMBL31517097 | 0.84 | CCR1 (0.46) | KDM4ENPC1GABRA1GABRA5GABRA3 | |
| SCHEMBL28008724 | 0.83 | KDM4E (0.50) | KDM4ENPC1GABRA1GABRA5GABRA3 | |
| SCHEMBL30610288 | 0.82 | NPC1 (0.47) | KDM4ENPC1LMNAMETAP1CCR1 | |
| SCHEMBL12203857 | 0.82 | NPC1 (0.47) | KDM4ENPC1LMNAMETAP1CCR1 | |
| SCHEMBL16806017 | 0.81 | KDM4E (0.50) | KDM4ENPC1LMNAMETAP1CCR1 | |
| SCHEMBL17427076 | 0.81 | KDM4E (0.57) | KDM4ENPC1LMNAMETAP1CCR1 | |
| SCHEMBL21022955 | 0.80 | NPC1 (0.49) | KDM4ENPC1LMNAMETAP1CCR1 | |
| SCHEMBL30776779 | 0.79 | KDM4E (0.55) | KDM4ENPC1LMNAMETAP1CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12120945-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-10-15 | — | — | US | disclosed |
| CN-117279468-A | Phosphorescent excimer with preferred molecular orientation as monochromatic emitter for display and illumination applications | 李健 | 2023-12-22 | — | — | CN | disclosed |
| CN-111527615-B | Phosphorescent excimer with preferred molecular orientation as monochromatic emitter for display and illumination applications | 李健 | 2023-10-17 | — | — | CN | disclosed |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | UNITED STATES DEPARTMENT OF ENERGY | 2023-08-03 | — | — | US | disclosed |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | UNITED STATES DEPARTMENT OF ENERGY | 2023-08-03 | — | — | US | disclosed |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | UNITED STATES DEPARTMENT OF ENERGY | 2023-08-03 | — | — | US | disclosed |
| US-11594688-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-02-28 | — | — | US | disclosed |
| US-20210193936-A1 | PHOSPHORESCENT EXCIMERS WITH PREFERRED MOLECULAR ORIENTATION AS MONOCHROMATIC EMITTERS FOR DISPLAY AND LIGHTING APPLICATIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-06-24 | — | — | US | disclosed |
| CN-111527615-A | Phosphorescent excimer molecules with preferred molecular orientation as monochromatic emitters for display and lighting applications | 李健 | 2020-08-11 | — | — | CN | disclosed |
| CN-101010339-B | Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions | BRISTOL MYERS SQUIBB CO | 2011-11-09 | — | — | CN | disclosed |
| CN-101495502-A | N-terminally modified GLP-1 receptor modulators | BRISTOL MYERS SQUIBB CO (US) | 2009-07-29 | — | — | CN | disclosed |
| CN-101282991-A | N-terminally modified GLP-1 receptor modulators | BRISTOL MYERS SQUIBB CO (US) | 2008-10-08 | — | — | CN | disclosed |
| CN-101010339-A | Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions | BRISTOL MYERS SQUIBB CO (US) | 2007-08-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210193936-A1 | PHOSPHORESCENT EXCIMERS WITH PREFERRED MOLECULAR ORIENTATION AS MONOCHROMATIC EMITTERS FOR DISPLAY AND LIGHTING APPLICATIONS | PDCD1LG2, DCX, EMC2 | KDM4E 4324/4885NPC1 3646/4885GABRA1 3706/4885 |
| US-11594688-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | PDCD1LG2, EML4, EMC3 | KDM4E 4181/4885NPC1 3725/4885GABRA1 3580/4885 |
| US-12120945-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | PDCD1LG2, EML4, EMC3 | KDM4E 4181/4885NPC1 3725/4885GABRA1 3580/4885 |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | PDCD1LG2, DCX, EMC2 | KDM4E 4324/4885NPC1 3646/4885GABRA1 3706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.